Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NOF Corporation (4403.T)
JPY2,763.50
+12.50 (+0.45%)
JP JPX Basic Materials Chemicals - Specialty
Address
Yebisu Garden Place Tower 150-6019
Tokyo, JP
Tokyo, JP
CEO
Koji Sawamura
Website
nof.co.jp
IPO
2001-01-01
ISIN JP3753400005
Also trades on
Other OTC · NOFCF (USD)
Tokyo Stock Exchange · 4403.T (JPY)
Description
NOF Corporation is a chemical manufacturing company based in Tokyo, Japan, with operations extending across Asia and globally. The firm structures its business into three primary divisions. Its Functional Chemicals segment produces a diverse range of industrial materials, including various fatty acid and oxide derivatives, specialized polymers and films, electronic components, and corrosion prevention solutions. The Life Science division focuses on products like MPC compounds, ingredients for drug delivery systems, nutritional oils, and health-promoting foods. Lastly, the Explosive & Propulsion division manufactures items such as industrial and defense explosives, rocket fuels, safety devices for vehicles, and metal goods. Additionally, NOF holds interests in logistics, insurance, and property management. The company was established in 1937.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY2,763.50
+12.50 (+0.45%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
859.6K
Beta
0.36
Float Shares
178.36M
Free Float %
78.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.12% | -10.34% | -9.28% | -6.41% | +4.48% | -3.17% | +27.83% | +37.68% | +53.70% | +369.56% | +1,525.90% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2,763.50
DCF (Unlevered)
3,695.64
+33.7%
DCF (Levered)
2,833.40
+2.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.09
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+8.3% ★ Q1'26: +25.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+14.6% ★ Q1'26: +73.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+18.4% ★ Q1'26: +18.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+15.8% ★ Q1'26: +20.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-3.1% ★ Q1'26: -2.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.07× ★ Q1'26: 0.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 4 Rev. Ana. 5 EPS Ana. |
Mar 2027 4 Rev. Ana. 5 EPS Ana. |
Mar 2028 5 Rev. Ana. 5 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
167.70B
est: 164.00B (+2.3%)
|
170.46B
est: 170.00B (+0.3%)
|
174.06B
est: 171.50B (+1.5%)
|
179.94B
est: 180.50B (-0.3%)
|
189.15B
est: 189.75B (-0.3%)
|
180.92B
est: 182.75B (-1.0%)
|
172.65B
est: 170.55B (+1.2%)
|
192.64B
est: 190.00B (+1.4%)
|
217.71B
est: 218.42B (-0.3%)
|
222.25B
est: 228.11B (-2.6%)
|
238.31B
est: 243.80B (-2.3%)
|
260.00B
257.50B – 262.50B
+6.6% YoY
|
298.25B
277.44B – 315.18B
+14.7% YoY
|
323.25B
314.20B – 334.81B
+8.4% YoY
|
309.00B
294.20B – 323.14B
-4.4% YoY
|
295.50B
281.35B – 309.03B
-4.4% YoY
|
311.00B
296.11B – 325.24B
+5.2% YoY
|
| EBITDA |
21.81B
est: 37.46B (-41.8%)
|
24.37B
est: 38.83B (-37.2%)
|
29.11B
est: 39.17B (-25.7%)
|
30.73B
est: 41.22B (-25.4%)
|
33.49B
est: 43.34B (-22.7%)
|
32.18B
est: 41.74B (-22.9%)
|
32.16B
est: 38.95B (-17.4%)
|
41.51B
est: 43.39B (-4.4%)
|
46.98B
est: 49.89B (-5.8%)
|
49.08B
est: 59.69B (-17.8%)
|
53.27B
est: 63.80B (-16.5%)
|
68.04B
67.38B – 68.69B
+6.6% YoY
|
78.05B
72.60B – 82.48B
+14.7% YoY
|
84.59B
82.22B – 87.61B
+8.4% YoY
|
80.86B
76.99B – 84.56B
-4.4% YoY
|
77.33B
73.62B – 80.87B
-4.4% YoY
|
81.38B
77.49B – 85.11B
+5.2% YoY
|
| EBIT |
17.09B
est: 32.32B (-47.1%)
|
19.37B
est: 33.50B (-42.2%)
|
24.34B
est: 33.79B (-28.0%)
|
25.82B
est: 35.57B (-27.4%)
|
28.44B
est: 37.39B (-23.9%)
|
26.87B
est: 36.01B (-25.4%)
|
26.60B
est: 33.61B (-20.8%)
|
35.60B
est: 37.44B (-4.9%)
|
40.63B
est: 43.04B (-5.6%)
|
42.14B
est: 51.76B (-18.6%)
|
45.31B
est: 55.33B (-18.1%)
|
59.00B
58.43B – 59.57B
+6.6% YoY
|
67.68B
62.96B – 71.52B
+14.7% YoY
|
73.36B
71.30B – 75.98B
+8.4% YoY
|
70.12B
66.76B – 73.33B
-4.4% YoY
|
67.06B
63.85B – 70.13B
-4.4% YoY
|
70.58B
67.20B – 73.81B
+5.2% YoY
|
| Net Income |
11.70B
est: 8.62B (+35.8%)
|
13.59B
est: 9.04B (+50.2%)
|
17.59B
est: 12.32B (+42.8%)
|
19.91B
est: 16.93B (+17.6%)
|
22.03B
est: 19.19B (+14.8%)
|
21.14B
est: 19.98B (+5.8%)
|
23.30B
est: 19.59B (+19.0%)
|
26.69B
est: 25.19B (+5.9%)
|
33.97B
est: 32.39B (+4.9%)
|
33.99B
est: 36.02B (-5.6%)
|
36.50B
est: 34.06B (+7.2%)
|
38.45B
37.54B – 40.01B
+12.9% YoY
|
41.30B
40.83B – 46.57B
+7.4% YoY
|
46.58B
44.96B – 51.56B
+12.8% YoY
|
49.81B
46.77B – 52.84B
+6.9% YoY
|
49.60B
46.51B – 52.55B
-0.4% YoY
|
53.85B
50.50B – 57.06B
+8.6% YoY
|
| SGA |
24.55B
est: 24.24B (+1.3%)
|
25.47B
est: 25.13B (+1.4%)
|
25.91B
est: 25.35B (+2.2%)
|
26.23B
est: 26.68B (-1.7%)
|
27.01B
est: 28.05B (-3.7%)
|
26.55B
est: 27.01B (-1.7%)
|
25.91B
est: 25.21B (+2.8%)
|
28.15B
est: 28.08B (+0.2%)
|
29.62B
est: 32.28B (-8.2%)
|
31.02B
est: 32.37B (-4.2%)
|
32.81B
est: 34.60B (-5.1%)
|
36.89B
36.54B – 37.25B
+6.6% YoY
|
42.32B
39.37B – 44.72B
+14.7% YoY
|
45.87B
44.59B – 47.51B
+8.4% YoY
|
43.85B
41.75B – 45.85B
-4.4% YoY
|
41.93B
39.92B – 43.85B
-4.4% YoY
|
44.13B
42.02B – 46.15B
+5.2% YoY
|
| EPS |
43.16
est: 36.33 (+18.8%)
|
50.94
est: 38.13 (+33.6%)
|
67.42
est: 51.93 (+29.8%)
|
76.99
est: 71.40 (+7.8%)
|
86.43
est: 80.90 (+6.8%)
|
83.91
est: 84.23 (-0.4%)
|
93.50
est: 82.59 (+13.2%)
|
107.92
est: 106.22 (+1.6%)
|
139.01
est: 136.57 (+1.8%)
|
141.17
est: 150.10 (-6.0%)
|
153.88
est: 157.31 (-2.2%)
|
168.50
163.23 – 174.01
+7.1% YoY
|
188.54
177.56 – 202.51
+11.9% YoY
|
213.93
195.52 – 224.22
+13.5% YoY
|
216.90
203.40 – 229.81
+1.4% YoY
|
215.70
202.27 – 228.54
-0.6% YoY
|
234.20
219.62 – 248.14
+8.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.77B
OE per share TTM
11.65
Owner's Yield
0.43%
Maintenance CapEx ratio
3.76%
Maint CapEx / Avg PPE
34.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 102 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.24% | 1.38M | 0.58% |
| 2 | iShares MSCI Japan Small-Cap ETF SCJ | 0.24% | 612.1K | 0.50% |
| 3 | Fidelity Japan Equity Research Enhanced UCITS ETF ACC-JPY FJPR.L | 0.13% | 427.0K | 0.25% |
| 4 | Avantis International Small Cap Equity ETF AVDS | 0.12% | 386.4K | 0.30% |
| 5 | Xtrackers FTSE Developed ex US Multifactor ETF DEEF | 0.10% | 54.8K | 0.24% |
| 6 | Schwab Fundamental International Small Company Index ETF FNDC | 0.09% | 2.76M | 0.39% |
| 7 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.09% | 205.7K | 0.83% |
| 8 | iShares MSCI EAFE Small-Cap ETF SCZ | 0.09% | 12.39M | 0.40% |
| 9 | Invesco JPX-Nikkei 400 UCITS ETF N4US.L | 0.08% | 165.2K | 0.19% |
| 10 | Invesco JPX-Nikkei 400 UCITS ETF N400.L | 0.08% | 164.9K | 0.19% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
12.22M
Shares Outstanding
226.43M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihisa Maeda | Operating Officer and GM of HR & General Affairs Dept. | — | — |
| Eui-Chul Kang | Executive Operating Officer & GM of Corporate R&D Div. | — | — |
| Junko Hamamoto | General Manager of Corporate Communications Dept. | — | — |
| Kazuyoshi Yamauchi | Managing Executive Officer, GM of Technology Hq., CSQO & Director | — | male |
| Koji Sawamura | President, Chief Executive Officer & Representative Director | — | — |
| Manabu Saito | CCO, Executive Operating Officer & Director | — | male |
| Naoya Umehara | Chief Financial Officer & Executive Operating Officer | — | male |
| Takeo Miyaji | Executive Officer & Chairman | — | male |
| Tsuneharu Miyazaki | Managing Executive Officer & GM of DDS Division | — | — |
| Tsuyoshi Izumisawa | Accounting Department Manager, Operating Officer & GM of Finance Department | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4403.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
